Treatment response and outcomes varied with different rearrangement partners of ZNF384. Patients with EP300-ZNF384 ALL had better prednisolone response [50] and EFS than other ZNF384-rearranged cases [48]. Here, ZNF384 is linked to acute lymphoblastic leukemia.